. Vi/-references,

T. Albrecht, I. Boldogh, F. M. Lee, C. Abubakar, S. Russell et al., Cellactivation responses to cytomegalovirus infection relationship to the phasing of CMV replication and to the induction of cellular damage, Subcell Biochem, vol.15, pp.157-202, 1989.

T. Albrecht and T. Weller, Heterogeneous morphologic features of plaques induced by five strains of human cytomegalovirus, Am J Clin Pathol, 1980.

W. Bügenler, T. Wagner, and . German, , vol.21, p.236, 1926.

T. Weller, Cytomegaloviruses: a Historical Perspective, The journal of the IHMF, 2000.

D. Medearis, Observations concerning human cytomegalovirus infection and disease, Bull Johns Hopkins Hosp, 1964.

R. Feldman, Cytomegalovirus infection during pregnancy: A prospective study and report of six cases, Am J Dis Child, 1969.

L. Davis, G. Tweed, J. Stewart, and M. Bernstein, Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus, Pediatrics, 1971.

H. Stern and S. Tucker, Prospective study of cytomegalovirus infection in pregnancy, Br Med J, 1973.

S. Jassogne and C. Historique, les grandes étapes de la recherche de 1926 à 1973.Séminaire EBIM, 2001.

T. Crough and R. Khanna, Immunobiology of human cytomegalovirus: from bench to bedside

, Clin Microbiol Rev, 2009.

M. J. Reddehase and N. Lemmermann, Cytomegaloviruses: molecular biology and immunology, 2006.

T. Compton, D. Nowlin, and N. Cooper, Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate, Virology, 1993.

J. Simpson, J. Chow, J. Baker, N. Avdalovic, S. Yuan et al., Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites, J Virol, 1993.

B. Ryckman, B. Rainish, M. Chase, J. Borton, J. Nelson et al., Characterization of the human cytomegalovirus gH/gL/UL128131 complex that mediates entry into epithelial and end othelial cells, J Virol, vol.82, issue.1, pp.60-70, 2007.

D. Wang and T. Shenk, Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism, J Virol, vol.79, issue.16, pp.10330-10338, 2005.

F. Wussow, Y. Yue, J. Martinez, J. Deere, J. Longmate et al., A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques, J Virol, vol.87, issue.3, pp.1322-1354, 2012.

W. Britt and S. Boppana, Human cytomegalovirus virion proteins, Hum Immunol, 2004.

N. Suárez, G. Wilkie, E. Hage, S. Camiolo, M. Holton et al., Human Cytomegalovirus Genomes Sequenced Directly from Clinical Material: Variation, Multiple-Strain Infection, Recombination and Gene Loss, J Infect Dis, vol.220, issue.5, pp.781-791, 2019.

M. Luo, P. Schwartz, and E. Fortunato, Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection, J Virol, 2008.

, , vol.82, pp.9994-10007, 2008.

C. Söderberg, T. Giugni, J. Zaia, S. Larsson, J. Wahlberg et al.,

, CD13 (human aminopeptidase N) mediates human cytomegalovirus infection

, J Virol, vol.67, issue.11, pp.6576-85, 1993.

T. Giugni, C. Söderberg, D. Ham, R. Bautista, K. Hedlund et al., Neutralization of human cytomegalovirus by human CD13-specific antibodies, J Infect Dis, vol.173, issue.5, pp.1062-71, 1996.

F. Halary, A. A. Lortat-jacob, H. Messerle, M. Delaunay, T. Houlès et al., Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection, Immunity, vol.17, issue.5, pp.653-64, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01061427

J. Mckeating, P. D. Griffiths, and J. E. Grundy, Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response?, J Gen Virol, vol.68, pp.785-92, 1987.

T. Compton, Receptors and immune sensors: the complex entry path of human cytomegalovirus, Trends Cell Biol, vol.14, issue.1, pp.5-8, 2004.

E. A. Fortunato, A. K. Mcelroy, I. Sanchez, and D. H. Spector, Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus, Trends Microbiol, vol.8, issue.3, pp.111-120, 2000.

K. Döhner, The role of the cytoskeleton during viral infection, Curr Top Microbiol Immunol, vol.285, pp.67-108, 2005.

A. L. Vanarsdall, B. J. Ryckman, M. C. Chase, and D. C. Johnson, Human cytomegalovirus glycoproteins gB and gH/gL mediate epthelial cell-cell fusion when expressed either in cis or in trans, J Virol, 2008.

, , vol.82, pp.11837-50, 2008.

M. Digel, K. L. Sampaio, G. Jahn, and C. Sinzger, Evidence for direct transfer of cytoplasmic material from infected to uninfected cells during cell-associated spread of human cytomegalovirus, J Clin Virol, vol.37, issue.1, pp.10-20, 2006.

T. H. Albrecht and . Weller, Heterogeneous morphologic features of plaques induced by five strains of human cytomegalovirus, Am J Clin Pathol, vol.73, issue.5, pp.648-54, 1980.

P. I. Sipos, Endothelial progenitor cells: their potential in the placental vasculature and related complications, Placenta, vol.31, issue.1, pp.1-10, 2009.

J. H. Lee and R. F. Kalejta, Human Cytomegalovirus Enters the Primary CD34+

, Hematopoietic Progenitor Cells where it Establishes Latency by Macropinocytosis

, J Virol, vol.93, issue.15, pp.452-471, 2019.

J. L. Stern and B. Slobedman, Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1

, J Immunol, vol.180, issue.10, pp.6577-85, 2008.

V. P. Young, M. C. Mariano, C. C. Tu, K. M. Allaire, S. Avdic et al., Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood, J Infect Dis, vol.215, issue.6, pp.874-882, 2017.

A. Petrucelli, M. Umashankar, P. Zagallo, M. Rak, and F. Goodrum, Interactions between proteins encoded within the human cytomegalovirus UL133-UL138 locus, J Virol, vol.86, issue.16, pp.8653-62, 2012.

J. C. Murphy, W. Fischle, E. Verdin, and J. H. Sinclair, Control of cytomegalovirus lytic gene expression by histone acetylation, MBO J, vol.21, issue.5, pp.1112-1132, 2002.

J. Sinclair and P. Sissons, Latency and reactivation of human cytomegalovirus

, J Gen Virol, vol.87, pp.1763-79, 2006.

, Prévention de l'infection à cytomégalovirus chez la femme enceinte et le nouveau-né

, 38) Infections à CMV : facteurs de risque, prophylaxie, traitement, résistance, 2018.

, Sophie Alain CNR des Cytomégalovirus Limoges

, Évaluation de l'intérêt du dépistage de l'infection à cytomégalovirus chez la femme enceinte en France, 2004.

L. Grangeot-keros, B. Simon, F. Audibert, and M. Vial, Should we routinely screen for cytomegalovirus antibody during pregnancy ?, Intervirology, vol.41, issue.4-5, pp.158-62, 1998.

S. Gouarin, P. Palmer, D. Cointe, S. Rogez, A. Vabret et al., Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR, J J Clin Virol, vol.21, issue.1, pp.47-55, 2001.

O. Picone, C. Vauloup-fellous, A. G. Cordier, I. Parent-du-châtelet, M. V. Senat et al., A 2-year study on cytomegalovirus infection during pregnancy in a French hospital, BJOG, vol.116, issue.6, pp.818-841, 2009.

D. Antona, A. Lepoutre, L. Fonteneau, C. Baudon, F. Halftermeyer-zhou et al., Seroprevalence of cytomegalovirus infection in France in 2010. Epidemiol Infect, 2017.

, , vol.145, pp.1471-1478, 2017.

M. G. Revello, M. Zavattoni, M. Furione, D. Lilleri, G. Gorini et al., Diagnosis and Outcome of Preconceptional and Periconceptional PrimaryHuman Cytomegalovirus Infections, Clin Microbiol Rev, vol.15, issue.4, pp.680-715, 2002.

G. Enders, A. Daiminger, U. Bader, S. Exler, and M. Enders, Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age

, J Clin Virol, vol.52, issue.3, pp.244-250, 2011.

S. Manicklal, V. C. Emery, T. Lazzarotto, S. B. Boppana, and R. K. Gupta, The ''silent" global burden of congenital cytomegalovirus, Clin Microbiol Rev, vol.26, issue.1, pp.86-102, 2013.

M. Bodéus, B. Kabamba-mukadi, F. Zech, C. Hubinont, P. Bernard et al., Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions, J Clin Virol, vol.47, issue.2, pp.201-203, 2009.

A. Kenneson and M. J. Cannon, Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection, Rev Med Virol, vol.17, issue.4, pp.253-76, 2007.

W. D. Rawlinson, S. B. Boppana, K. B. Fowler, D. W. Kimberlin, T. Lazzarotto et al., Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis, vol.17, pp.177-188, 2017.

S. B. Boppana, R. F. Pass, W. J. Britt, S. Stagno, and C. A. Alford, Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality, Pediatr Infect Dis J, vol.11, issue.2, pp.93-102, 1992.

S. B. Boppana, S. A. Ross, and K. B. Fowler, Congenital cytomegalovirus infection: clinical outcome, Clin Infect Dis, vol.57, issue.4, pp.178-81, 2013.

A. J. Dahle, K. B. Fowler, J. D. Wright, S. B. Boppana, W. J. Britt et al., Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus, J Am Acad Audiol, 2000.

C. S. Kraft, W. S. Armstrong, and A. M. Caliendo, Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective, Clin Infect Dis, vol.54, issue.12, pp.1793-1800, 2012.

Y. Sellier, Déterminants immuno-virologiques de l'infection congénitale à cytomégalovirus dans les prélèvements foetaux périphériques et dans le tissu cérébral. Thèse de doctorat en virologie 06 octobre, 2016.

S. Lipitz, C. Hoffmann, B. Feldman, M. Tepperberg-dikawa, E. Schiff et al., Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection, Ultrasound Obstet Gynecol, vol.36, issue.6, pp.709-726, 2010.

S. A. Ross, A. Ahmed, A. L. Palmer, M. G. Michaels, P. J. Sánchez et al., National Institute on Deafness and Other Communication Disorders CHIMES Study. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens, J Infect Dis, vol.210, issue.9, pp.1415-1423, 2014.

S. A. Ross, A. Ahmed, A. L. Palmer, M. G. Michaels, P. J. Sánchez et al., National Institute on Deafness and Other Communication Disorders CHIMES Study. Urine Collection Method for the Diagnosis of Congenital Cytomegalovirus Infection, Pediatr Infect Dis J, vol.34, issue.8, pp.903-908, 2015.

S. Boppana, C. Amos, W. Britt, S. Stagno, C. Alford et al., Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection, Pediatr Infect Dis J, 1994.

K. Shoji, N. Ito, Y. Ito, N. Inoue, S. Adachi et al.,

. Pediatr, Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?, J Pediatr, vol.157, issue.2, pp.331-334, 2010.

D. W. Kimberlin, C. Y. Lin, P. J. Sánchez, G. J. Demmler, W. Dankner et al., Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial, J Pediatr, vol.143, issue.1, pp.16-25, 2003.

S. E. Oliver, G. A. Cloud, P. J. Sánchez, G. J. Demmler, W. Dankner et al.,

W. Pass, R. F. Soong, S. J. Whitley, R. J. Kimberlin, and D. W. , Infectious Diseases Collaborative Antiviral Study Group. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

, J Clin Virol, vol.46, pp.22-28, 2009.

. Lackner-a-1, A. Acham, T. Alborno, M. Moser, H. Engele et al., Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up, J Laryngol Otol, vol.123, issue.4, pp.391-397, 2008.

Z. Vancíková, Perinatal cytomegalovirus hepatitis: to treat or not to treat with ganciclovir

J. Health, , vol.40, pp.444-452, 2004.

P. Garcia, A. Maillotte, and . Protocole-pédiatrique-n°7, Cytomégalovirus (CMV) ET NOUVEAU-NÉ. Réseau méditéranée, 2019.

M. Leruez-ville and Y. Ville, Infection à cytomegalovirus pendant la grossesse : enjeux et prise en charge . Infections et grossesse, Tome, vol.43, issue.6, p.2014

D. W. Kimberlin, Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir congenital in treatment of symptomatic congenital cytomegalovirus disease, J Infect Dis, 2008.

. Kurath, Transmission of Cytomegalovirus via Breast Milk to the Prematurely Born Infant

, Clin Microbiol Infect, vol.16, issue.8, pp.1172-1180, 2010.

. Maschmann, Characterization of Human Breast Milk Leukocytes and Their Potential Role in Cytomegalovirus Transmission to Newborns, Neonatology, vol.107, issue.3, pp.213-222, 2015.

. Hamprecht, Epidemiology of Transmission of Cytomegalovirus from Mother to Preterm Infant by Breastfeeding, Lancet, vol.357, issue.9255, pp.513-521, 2001.

. Neuberger, Case-Control Study of Symptoms and Neonatal Outcome of Human milk-Transmitted Cytomegalovirus Infection in Premature Infants, J Pediatr, vol.148, issue.3, pp.326-357, 2006.

. Capretti, Very Low Birth Weight Infants Born to Cytomegalovirus-Seropositive Mothers Fed with Their Mother's Milk, J Pediatr, vol.154, issue.6, pp.842-850, 2009.

. Lanzieri, Breast Milk-Acquired Cytomegalovirus Infection and Disease in Very Low Birth Weight and Premature Infants, Pediatrics, vol.131, issue.6, pp.1937-1982, 2013.

J. Gunkel, T. F. Wolfs, L. S. De-vries, and J. Nijman, Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment, Expert Rev Anti Infect Ther, 2014.

M. Hamele, R. Flanagan, C. A. Loomis, T. Stevens, M. P. Et et al., Severe morbidity and mortality with breast milk associated cytomegalovirus infection, Pediatr Infect Dis J, vol.29, issue.1, pp.84-90, 2010.

K. Hamprecht, G. Rangmar, and J. M. , Breast milk and cytomegalovirus infection in preterm infants, Early Hum Dev, vol.81, issue.12, pp.989-96, 2005.

S. Luck and M. Sharland, Postnatal cytomegalovirus: innocent bystander or hidden problem? Arch Dis Child Fetal Neonatal Ed, 2009.

J. Gunkel, S. De-vries, L. Jongmans, M. Koopman-esseboom, C. et al., Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection. Pediatrics, vol.141, 2018.

B. Fischler, T. H. Casswall, P. Malmborg, and A. Nemeth, Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis, J Pediatr Gastroenterol Nutr, vol.34, issue.2, pp.154-161, 2002.

G. Nigro, A. Krzysztofiak, U. Bartmann, A. Clerico, E. Properzi et al., Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children, Arch Virol, vol.142, issue.3, pp.573-80, 1997.

R. Takahashi, M. Tagawa, M. Sanjo, H. Chiba, T. Ito et al., Severe postnatal cytomegalovirus infection in a very premature infant, Neonatology, vol.92, issue.4, pp.236-245, 2007.

J. L. Cheong, F. M. Cowan, and N. Modi, Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period, Arch Dis Child Fetal Neonatal Ed, vol.89, issue.4, pp.367-376, 2004.

D. A. Gidrewicz and T. R. Fenton, A systematic review and meta-analysis of the nutrient content of preterm and term breastmilk, BMC Pediatr, vol.14, p.216, 2014.

J. Shulhan, B. Dicken, L. Hartling, and B. M. Larsen, Adv Nutr. Current Knowledge of Necrotizing Enterocolitis in Preterm Infants and the Impact of Different Types of Enteral Nutrition Products, vol.8, pp.80-91, 2017.

J. Miller, E. Tonkin, R. A. Damarell, A. J. Mcphee, M. Suganuma et al., A Systematic Review and Meta-Analysis of Human Milk Feeding and Morbidity in Very Low Birth Weight Infants, Nutrients, vol.10, issue.6, 2018.

M. Quigley, N. D. Embleton, and W. Mcguire, Formula versus donor breast milk for feeding preterm or low birth weight infants, Cochrane Database of Systematic Reviews, 2019.

M. Clarke, Effect of Antimicrobial Factors in Human Milk on Rhinoviruses and Milk-Borne Cytomegalovirus in Vitro, J Med Microbiol, vol.49, issue.8, pp.719-742, 2000.

J. C. Picaud and R. Buffin, Human milk-treatment and quality of banked human milk, Clin Perinatol, vol.44, issue.1, pp.95-119, 2016.

O. Dicky, V. Ehlinger, N. Montjaux, G. Gremmo-féger, J. Sizun et al., Policy of Feeding Very Preterm Infants with Their Mother's Own Fresh Expressed Milk Was Associated with a Reduced Risk of Bronchopulmonary Dysplasia, Acta Paediatr, 2017.

, , vol.106, pp.755-762, 2017.

J. C. Picaud, R. Buffin, G. Gremmo-feger, J. Rigo, G. Putet et al., Review Concludes That Specific Recommendations Are Needed to Harmonise the Provision of Fresh Mother's Milk to Their Preterm Infants, Acta Paediatr, vol.107, issue.7, pp.1145-1155, 2018.

, Règles de bonnes pratiques de collecte, de préparation, de qualification, de traitement, de conservation, de distribution et de délivrance sur prescription médicale du lait humain par les lactariums, AFSSAPS, 2008.

, Section on Breastfeeding.Breastfeeding and the use of human milk, American academy of Pediatrics, vol.129, issue.3, pp.827-868, 2012.

S. Kurath and B. Resch, Cytomegalovirus and transmission via breast milk: how to support breast milk to premature infants and prevent severe infection?, Pediatr Infect Dis J, vol.29, issue.7, pp.680-681, 2010.

S. Kurath, G. Halwachs-baumann, W. Müller, and B. Resch, Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review, Clin Microbiol Infect, vol.16, issue.8, pp.1172-1180, 2010.

K. F. Brecht, R. Goelz, A. Bevot, I. Krägeloh-mann, M. Wilke et al., Postnatal human cytomegalovirus infection in preterm infants has long-term neuropsychological sequelae

, J Pediatr, vol.166, issue.4, pp.834-843, 2014.

J. Gonya, , p.1

C. William and . Ray, Investigating skin-to-skin care patterns with extremely preterm infants in the NICU and their effect on early cognitive and communication performance: a retrospective cohort study, BMJ Open, vol.7, issue.3, p.12985, 2017.